eslicarbazepine acetate 800 MG Oral Tablet [Aptiom]
- RxCUI
- 1482527
- RxNorm name
- eslicarbazepine acetate 800 MG Oral Tablet [Aptiom]
- Display name
- eslicarbazepine acetate 800 MG Oral Tablet [Aptiom]
- Full name
- eslicarbazepine acetate 800 MG Oral Tablet [Aptiom]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aptiom | ESLICARBAZEPINE ACETATE | Sumitomo Pharma America, Inc. | 3d0c9554-eaeb-4694-8089-00133fcadce3 | 2023-11-10 | Warnings, Adverse reactions | 1482527 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3d0c9554-eaeb-4694-8089-00133fcadce3 | eslicarbazepine acetate 800 MG Oral Tablet [Aptiom] | SBD | 16 | These highlights do not include all the information needed to use APTIOM safely and effectively. See full prescribing information for APTIOM. APTIOM ® (eslicarbazepine acetate) tablets, for oral use Initial U.S. Approval: 2013 | 20231110 |
| 3d0c9554-eaeb-4694-8089-00133fcadce3 | Aptiom 800 MG Oral Tablet, Once Daily | PSN | 16 | These highlights do not include all the information needed to use APTIOM safely and effectively. See full prescribing information for APTIOM. APTIOM ® (eslicarbazepine acetate) tablets, for oral use Initial U.S. Approval: 2013 | 20231110 |
| 3d0c9554-eaeb-4694-8089-00133fcadce3 | Aptiom 800 MG Oral Tablet | SY | 16 | These highlights do not include all the information needed to use APTIOM safely and effectively. See full prescribing information for APTIOM. APTIOM ® (eslicarbazepine acetate) tablets, for oral use Initial U.S. Approval: 2013 | 20231110 |